Skip to main content
FinSpry Logo
FinSpry
SLN logo
SLN
(NASDAQ)
Silence Therapeutics plc
$11.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Silence Therapeutics (SLN) Stock Price & Financial Analysis

Silence Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.21 - $11.89
52-Week High$11.90
52-Week Low$4.19
Open$11.75
Volume468.70K
Average Volume (3M)570.88K
Market Cap540.83M
Shares Outstanding47.23M
Price to Sales (P/S)645.16
Price to Book (P/B)10.95
EV/EBITDA-6.95
Revenue (TTM)838.29K
Net Income (TTM)-75.01M
Free Cash Flow (TTM)-65.62M
EPS (TTM)$-1.59
Profit Margin-8948.43%
Operating Margin-9267.51%
Return on Equity (ROE)-151.84%
Debt to Equity0.00
50-Day MA$8.17
200-Day MA$6.66
52-Week Change86.18%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Silence Therapeutics

What is the current stock price for SLN?

As of the latest trading session, SLN stock trades at $11.45. The 52-week range is $4.19–$11.90, with a day range of $11.21–$11.88.

What is the P/E ratio for SLN?

The P/E ratio (Price-to-Earnings) for SLN is shown in the Key Statistics section. This valuation metric helps compare Silence Therapeutics plc to industry peers.

Does SLN pay dividends?

Silence Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SLN?

Based on 5 analysts, the consensus for SLN is Buy.

What is the market cap of SLN?

Silence Therapeutics's market capitalization is $540.8M, classifying it as a small-cap company. Silence Therapeutics operates in the Healthcare sector within the Biotechnology industry.